Epitope Inc. signed a collaborative research agreement with E.I. du Pont de Nemours & Co. for development of novel commercial plant varieties.
Under terms of the agreement, Epitope and Du Pont scientists will combine research efforts in gene transfer and plant tissue culture toward production of specialized varieties. Epitope and Du Pont will retain jointly all rights to the new plant varieties.A.J. Ferro, Epitope vice president of research and development, said: The agreement involves 'controlled ripening' which has broad commercial applications in the agricultural industry.
If successful, controlled ripening - accomplished via gene transfer - could ultimately increase agricultural yield, extend bloom life in flowers, synchronize ripening cycles, prolong postharvest storage life and provide crop resistance to injury and stress.
Analysts predict an annual growth rate of over 60 percent in the agbiotech area.